Pharmacokinetics of Remifentanil in Chinese Patients Undergoing Elective Surgery

ZHANG Li-ping,LI Min,ZHANG Chao,ZHANG Xian-hua
2006-01-01
Abstract:Aim To study the pharmacokinetics of remifentanil in Chinese adult patients undergoing elective surgery and compare the results with the data already published. Methods The pharmacokinetics of remifentanil was determined in 10 adult patients undergoing elective surgery. Remifentanil 5 - 6 μg·kg-1 was administered within 1 min after the induction of anesthesia. One point five millilitre of arterial blood samples were collected at 0 (baseline), 1, 2, 3, 5, 7, 10, 15, 20, 25, 30, 45, 60, and 90 min after drug administration. Remifentanil concentration was assayed by HPLC/MS/MS. Results The concentration-time course of remifentanil was best described by a two-compartment model. Total clearance (CL = 2.149 ± 0.431 L·min-1) of remifentanil was greater than the normal hepatic blood flow. The distribution half-life (t1/2 α) [1.56 ± 0.52 min (0.73 - 2.31)] and the elimination half-life (t1/2 β) [22.07 ± 10.30 min (9.71-36.07)] were similar with those in previous reports. Volume of distribution (Vd = 65.766 ± 29.100 L) was about two times greater than that reported in previous studies of other ethnics. Conclusion In the present study, the volume of distribution is significantly greater than that reported in previous studies of other ethnics, indicating that there are some differences in the pharmacokinetics of remifentanil among different ethnics.
What problem does this paper attempt to address?